Jennifer M. Adams-Haduch

TL;DR: The use of combination therapy for definitive therapy appears to be associated with improved survival in bacteremia due to KPC-producing K. pneumoniae.

TL;DR: A substantial portion of community-onset, ESBL-producing E. coli infections now occur among patients without discernible healthcare-associated risk factors in the United States, which has implications for the empiric management ofcommunity-associated infection when involvement of E. bacteria is suspected.

TL;DR: The presence of the carbapenemase gene blaOXA-23 and the 16S rRNA methylase gene armA predicted high-level resistance to imipenem and amikacin, respectively, and typical substitutions in the quinolone resistance-determining regions of the gyrA and parC genes were observed in the ciprofloxacin-resistant isolates.

TL;DR: Community and healthcare environments are now significant reservoirs of ESBL-producing and CMY-producing E. coli, and retail meat is a potential source of these organisms.

TL;DR: Five cases of infection due to colistin-resistant, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae belonging to the international epidemic clone ST258 occurred over a 4-month period and likely represented both emergence of resistance and transmission of resistant organism.